M&A Deal Summary

Antech Diagnostics Acquires Biovet

On October 23, 2019, Antech Diagnostics acquired life science company Biovet

Acquisition Highlights
  • This is Antech Diagnostics’ 2nd transaction in the Life Science sector.
  • This is Antech Diagnostics’ 1st transaction in Canada.
  • This is Antech Diagnostics’ 1st transaction in Quebec.

M&A Deal Summary
Date 2019-10-23
Target Biovet
Sector Life Science
Buyer(s) Antech Diagnostics
Deal Type Add-on Acquisition

Target

Biovet

Saint-Hyacinthe, Quebec, Canada
Biovet, Inc. is a biotechnology company providing unique expertise in the field of diagnostics for animal health and agro-industry specialists in Canada and internationally. Biovet is based in Saint-Hyacinthe, Quebec.

Search 201,157 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Antech Diagnostics

Irvine, California, United States
Category Company
Founded 1994
Sector Healthcare Services
DESCRIPTION

Antech Diagnostics, Inc. is an provider of health care services for animals.

DEAL STATS #
Overall 2 of 3
Sector (Life Science) 2 of 2
Type (Add-on Acquisition) 1 of 2
State (Quebec) 1 of 1
Country (Canada) 1 of 1
Year (2019) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-03-19 Abaxis Veterinary Reference Laboratory

United States

Abaxis Veterinary Reference Laboratory (AVRL) is a provider of diagnostic solutions.

Buy $21M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-09 Eurolyser

Salzburg, Austria

Eurolyser designs and engineers patented point-of-care testing equipment and kits, diagnosing a wide range of conditions in animals and humans. Point-of-care testing is done at the time of consultation, leading to the immediate availability of results and more timely, informed decisions concerning treatment. Eurolyser was founded in 2005 and is headquartered in Salzburg, Austria.

Buy -
Mergr

Product

Company

Legal